Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

16:10 IST NSE
AcquisitionSamhi Hotels Ltd SAMHI

Samhi Hotels Acquisition Worth ₹1.46 Cr

SAMHI Hotels is investing ₹1.46 Crore to acquire a 26% stake in Clean Max Solomon Private Limited. This strategic investment in a 4.05 MWp solar project in Karnataka enables captive renewable energy consumption for SAMHI's subsidiaries, ensuring compliance with electricity laws and reducing operational carbon footprint.

Value
₹1.46 Cr
Execution
15-05-2026
16:07 IST NSE
PartnershipInfosys Ltd INFY

Infosys Partnership

Infosys has signed a multi-year partnership with tennis champion Carlos Alcaraz, appointing him as Global Brand Ambassador. The collaboration focuses on developing AI-powered match analytics and personalized performance applications using Infosys Topaz. Additionally, the partnership extends to joint tech-for-good initiatives through the Carlos Alcaraz Foundation.

Execution
multi-year
16:05 IST BSE
Financial ResultsAditya Birla Housing Finance Ltd

Aditya Birla Housing Finance Q4 FY26 Results: Net Profit ₹200 Cr, Up 112.8% YoY

Aditya Birla Housing Finance Limited approved its audited FY2026 financial results and a ₹750 Crore capital infusion. The board also approved increasing borrowing limits and issuing non-convertible securities. These strategic decisions aim to strengthen the company's capital base and support continued lending growth.

Key figure
Net profit ₹200 Cr · +112.8% YoY
16:04 IST NSE
AcquisitionRubicon Research Ltd RUBICON

Rubicon Research Acquisition Worth ₹175.9 Cr

Rubicon Research Limited is acquiring an 85% stake in Arinna Lifesciences Limited for approximately ₹175.92 Crore. Arinna is a specialist in the CNS therapeutic segment with a dedicated field force. This acquisition allows Rubicon to leverage its IP and chronic products portfolio while gaining access to Arinna’s established Indian sales and distribution network.

Value
₹175.9 Cr
Execution
One month
16:01 IST BSE
Debt & BorrowingPiramal Finance Ltd PIRAMALFIN

Piramal Finance Debt & Borrowing: ₹26,189 Cr

Piramal Finance Limited reported its outstanding Non-Convertible Debentures (NCDs) for the half-year ended March 31, 2026. The company has 32 series of listed NCDs with a total outstanding value of ₹26,189.23 Crore. This disclosure is a routine regulatory requirement under SEBI Master Circulars for listed debt securities.

Value
₹26,189 Cr
16:01 IST BSE
Capacity ExpansionAurobindo Pharma Ltd AUROPHARMA

Aurobindo Pharma Capacity Expansion: ₹1,395 Cr Investment

Aurobindo Pharma's subsidiary, TheraNym Biologics, will invest approximately ₹1395.0 Crore (USD 150M) to establish a new large-scale mammalian manufacturing facility ('Unit 2'). This greenfield project expands an existing CMO relationship with Merck Sharpe & Dohme (MSD) and will house 60 KL of bioreactor capacity.

Value
₹1,395 Cr
15:56 IST BSE
Debt & BorrowingTata Power Company Ltd TATAPOWER

Tata Power Company Debt & Borrowing: ₹5,200 Cr

The Tata Power Company Limited submitted its half-yearly report for debt securities for the period ended March 31, 2026. The filing details nine outstanding Non-Convertible Debentures (NCDs) with a total issued amount of ₹5,200 Crore. This disclosure ensures regulatory compliance with SEBI's master circular on debt listing and reporting.

Value
₹5,200 Cr
15:54 IST NSE
Debt & BorrowingPower Finance Corporation Ltd PFC

Power Finance Corporation Debt & Borrowing: ₹3,000 Cr

Power Finance Corporation Limited has successfully paid ₹3,000.00 Crore towards the redemption and interest of its Commercial Paper series 120. The payment was completed on the due date of April 15, 2026. This timely settlement demonstrates the company's strong liquidity and commitment to its debt obligations.

Value
₹3,000 Cr
15:53 IST NSE
Management ChangeAstec Lifesciences Ltd ASTEC

Astec Lifesciences Management Change

Astec LifeSciences Limited announced a major management shuffle effective April 13, 2026. Nadir Godrej will retire, while Vishal Sharma is appointed as CEO (Chemicals). Burjis Godrej transitions to a Non-Executive Director role. Additionally, Mathew Eipe joins as an Independent Director and Arijit Mukherjee is appointed to the Board, strengthening leadership across the Godrej Industries Group.

15:46 IST BSE
Annual General MeetingCybele Industries Ltd CYBELEIND

Cybele Industries Annual General Meeting

Cybele Industries Ltd has issued a postal ballot notice seeking shareholder approval for material related party transactions and a ₹50 Crore limit for asset mortgages. Remote e-voting commences on April 16, 2026, and concludes on May 15, 2026. These resolutions aim to support business growth and operational requirements.

Value
₹50.00 Cr
15:46 IST BSE
Debt & BorrowingStar Source Multi Trade Ltd CHEMOPH

Star Source Multi Trade Debt & Borrowing: ₹0.01 Cr

Starsource Multitrade Limited submitted its initial disclosure for FY 2026 under the SEBI Large Corporate framework. The company confirmed it does not meet the Large Corporate criteria as of March 31, 2026, reporting incremental outstanding borrowings of ₹0.01 Crore. This filing is a routine regulatory requirement to monitor corporate debt sourcing from the bond market.

Value
₹0.01 Cr
15:45 IST BSE
Product LaunchGoodyear India Ltd GOODYEAR

Goodyear India Product Launch

Goodyear India Limited launched two new products, Eagle F1 Asymmetric 6 and Eagle F1 Asymmetric 6 SUV, on April 15, 2026. These tyres cater to the domestic replacement market and will be manufactured by Goodyear South Asia Tyres Pvt. Ltd. in Aurangabad.